Compare Johnson & Johnson (JNJ) vs Twilio Inc (TWLO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Johnson & Johnson vs Twilio Inc — how do they compare? Johnson & Johnson trades at $261.44 (market cap $618.09B), while Twilio Inc trades at $289.47 (market cap $42.35B). The key difference: Johnson & Johnson is far larger — about 14.6× Twilio Inc's market cap, and Johnson & Johnson pays a 2.09% dividend while Twilio Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Johnson & Johnson for 129 Days and Twilio Inc for 56 Days on average.
| JNJ | TWLO | |
|---|---|---|
Market Cap | $618.09B | $42.35B |
Volume | 6,050,983 | 1,862,642 |
Sector | Health | Technology |
52-Week High | $278.43 | $301.27 |
52-Week Low | $186.00 | $106.23 |
Typical Hold Time | 129 Days | 56 Days |
Enterprise Value | $646.37B | $40.76B |
Dividend Yield | 2.09% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Johnson & Johnson (JNJ) trades at $256.48, down 0.76% on the day, with the stock showing mixed technical signals amid a bearish overall trend. The company maintains strong fundamentals with $94.19B in 2025 revenue, 21.48% net income margin, and consistent earnings beats in recent quarters. Recent analyst coverage shows 52.5% buy ratings with a $286.53 consensus price target, while technical indicators point to key support at $248 and resistance at $258.
JNJ presents a compelling long-term investment case with robust profitability, diversified healthcare portfolio, and dividend stability, though near-term headwinds include patent expirations and competitive pressures. The stock's current valuation at 29.75 P/E appears reasonable given strong cash flow generation and pipeline innovation, with upside potential to analyst targets if execution continues.
Twilio (TWLO) trades at $275.77, up 1.01% on the day, with a bullish technical signal from moving averages and recent earnings beats. The company has shown strong revenue growth, reaching $5.07B in 2025, and a significant improvement in net income to $33.83M. Recent news highlights its upcoming inclusion in the S&P 500 index, reflecting increased market recognition and institutional interest.
Outlook is positive with accelerating revenue growth and profitability, supported by AI-driven communication services. Key risks include high valuation multiples and competitive pressures. Analyst consensus is bullish with a 76.92% buy rating, though price targets suggest near-term consolidation potential from current levels.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Johnson & Johnson
Johnson & Johnson manufactures health care products and provides related services for the consumer, pharmaceutical, and medical devices and diagnostics markets. The Company sells products such as skin and hair care products, acetaminophen products, pharmaceuticals, diagnostic equipment, and surgical equipment in countries located around the world.
Read more on JNJ →About Twilio Inc
Twilio Inc. is a cloud-based communication platform-as-a-service company offering communication building blocks that allow for a fully customized customer engagement experience spanning voice, video, chat, and SMS messaging. It does this through various application programming interfaces, or APIs, and prebuilt solution applications aimed at improving customer engagement. The company leverages its Super Network, a global network of carrier relationships, to facilitate high-speed, cost-effective communication.
Read more on TWLO →
